David Grayzel of Cambridge, MA appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. David Grayzel appears on 14 filing roles across Form D (13), Form ADV (1).
| Filed | Source | Entity | Role | Location |
|---|---|---|---|---|
| 2025-04-01 | Form ADV | ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | MEMBER | CAMBRIDGE, MA |
| 2014-04-17 | Form D | Annovation BioPharma, Inc. | Director | Cambridge, MA |
| 2011-07-29 | Form D | Arteaus Therapeutics, LLC | Director | CAMBRIDGE, MA |
| 2014-12-18 | Form D | Atlas Venture Fund X, L.P. | Executive Officer | CAMBRIDGE, MA |
| 2018-01-31 | Form D | Akriveia Therapeutics, LLC | Director | SKILLMAN, NJ |
| 2017-06-30 | Form D | Atlas Venture Fund XI, L.P. | Executive Officer | CAMBRIDGE, MA |
| 2019-01-02 | Form D | Atlas Venture Opportunity Fund I, L.P. | Executive Officer | CAMBRIDGE, MA |
| 2025-10-14 | Form D | Affinia Therapeutics Inc. | Director | WALTHAM, MA |
| 2020-06-04 | Form D | Atlas Venture Fund XII, L.P. | Executive Officer | CAMBRIDGE, MA |
| 2025-12-04 | Form D | Triana Biomedicines, Inc. | Director | LEXINGTON, MA |
| 2021-02-26 | Form D | Xilio Therapeutics, Inc. | Director | WALTHAM, MA |
| 2021-10-01 | Form D | Atlas Venture Opportunity Fund II, L.P. | Executive Officer | CAMBRIDGE, MA |
| 2022-03-03 | Form D | Atlas Venture Fund XIII, L.P. | Executive Officer | CAMBRIDGE, MA |
| 2024-12-05 | Form D | Atlas Venture Fund XIV, L.P. | Executive Officer | CAMBRIDGE, MA |